Chitosan-DNA nanoparticles: effect on DNA integrity, bacterial transformation and transfection efficiency.
While somatic gene therapy has the potential to treat many genetic disorders, recent clinical trials suggest that an efficient and safe delivery vehicle for successful gene therapy is lacking. The current study examines the influence of two different preparation (the solvent evaporation method and the complex coacervation method) methods on the encapsulation of a model plasmid with chitosan. The ability of different molecular weights of chitosan to form nanoparticles with a plasmid, and particulated polymers to stabilize a plasmid in a supercoiled form, were examined by agarose gel electrophoresis. Protection of encapsulated pDNA offered by these nanoparticles from nuclease attack was confirmed by assessing degradation in the presence of DNase I, and the transformation of the plasmids with incubated nanoparticles were examined by beta-galactosidase assay. Model pDNA existed as a mixture of both supercoiled (84.2%) and open circular (15.8%) forms. Our results demonstrated that supercoiled forms decreased while open circular forms and fragmented linear forms increased during the preparation of formulations. F1 formulation prepared by the complex coacervation method protected the supercoiled form of pDNA effectively. There weren't any significant changes in nanoparticle size and zeta potential values at pH 5.5 for a period of 3 months, but differences in particle sizes were observed after lyophilization with a cryoprotective agent. The efficiency of nanoparticles mediated transformation to Escherichia coli cells was significantly higher than naked DNA or poly-L-lysine (PLL)-DNA polycation complexes. The transfection studies were performed in COS-7 cells. A 3-fold increase in gene expression was produced by nanoparticles as compared to the same amount of naked plasmid DNA (pDNA). These observations suggest that formulations with high molecular weight (HMW) chitosan can be an effective non-viral method of gene vector in animal studies.
Bozkir
Asuman
A
Department of Pharmaceutical Technology, Faculty of Pharmacy, Ankara University, Tandogan, Turkey. bozkir@pharmacy.ankara.edu.tr
Saka
Ongun Mehmet
OM
D000818:Animals; D019556:COS Cells; D002686:Chitin / Q000008:administration & dosage*; D004247:DNA / Q000008:administration & dosage*; D004926:Escherichia coli / Q000235:genetics; D049329:Nanostructures; D010957:Plasmids; D014162:Transfection; D014169:Transformation, Bacterial
D002686:Chitin; D004247:DNA